Metformin and berberine: a careful comparison

Berberine is being called “natural metformin” on social media, and more and more people are buying it as a sugar or weight control supplement. The comparison has certain grounds: both substances affect carbohydrate metabolism and, in part, through similar cellular mechanisms. But there are significant differences between the medicine with more than sixty years of history and the plant alkaloid, which the editors analyze in this material.

Two substances with plant roots

Interestingly, metformin also has a plant "ancestor". Galega officinalis was used in folk medicine in Europe for symptoms that today are associated with diabetes. The active substance of this plant - galegine - became the starting point for the synthesis of biguanides, and metformin was first used in the clinic in the late 1950s.

Berberine is a yellow-colored alkaloid found in the bark and roots of barberry, goldenseal, Chinese coptis, and other plants. It has been used for centuries in traditional Chinese and Ayurvedic medicine, primarily for intestinal infections and diarrhea. The hypoglycemic effect of berberine was described much later.

So both substances are of "natural" origin, but metformin has gone from a plant extract to a standardized synthetic molecule with a large evidence base. Berberine mostly remains an extract or an isolated substance in supplements.

This difference determines everything else: from quality guarantees to how confidently you can talk about benefits and risks. "Naturalness" in itself is not an indicator of either effectiveness or safety.

Status: Medicine vs Supplement

Metformin is an established, inexpensive prescription medicine for type 2 diabetes and is on the WHO essential medicines list. It remains a common initial option, but ADA 2026 treatment selection is individualized: cardiovascular disease, heart failure, kidney disease and other priorities can favor other agents, with or without metformin.

Berberine in Ukraine, the EU and the USA is sold mainly as a dietary supplement. This means that the manufacturer is not obliged to prove effectiveness, and quality control is much softer than for drugs. The content of the active substance, its purity and the absence of impurities depend on the responsibility of the specific manufacturer.

For a person with diagnosed diabetes, this is a fundamental difference. Substitution of prescribed metformin for a supplement on one's own initiative can lead to worsening of glycemic control and, therefore, to the progression of complications.

At the same time, the situation is different for a person without diabetes who wants to influence the metabolic parameters: metformin is usually not prescribed solely for that purpose, and berberine is freely available. This is where the temptation of "natural metformin" arises, which should be evaluated soberly.

Evidence base: what has been proven and to what extent

There are results of large randomized trials for metformin. In UKPDS 34 (1998), in overweight patients with type 2 diabetes, metformin reduced the risk of diabetes-related complications and all-cause mortality compared with usual care. In the Diabetes Prevention Program (DPP, 2002), metformin reduced the incidence of diabetes in people with prediabetes, although lifestyle changes were more effective.

For berberine, the basis is smaller studies, mostly conducted in China. In Yin et al. (2008), berberine at a dose of 0.5 g three times daily for three months reduced glycated hemoglobin and fasting glucose in patients with type 2 diabetes similar to metformin. Meta-analyses confirm the sugar-lowering and lipid-lowering effect, but indicate the low quality of many studies.

Studies including Kong et al. (2004) reported LDL and triglyceride reductions with berberine through mechanisms distinct from statins. Such biomarker changes do not establish superiority over metformin for clinical outcomes or make berberine a substitute for indicated lipid-lowering treatment.

However, there are no studies showing a reduction in cardiovascular events, heart attacks, or mortality for berberine. Editor's note: Berberine has strong "lab" data, but its impact on real-world health outcomes is unknown.

Metformin, berberine and exercise

Metformin is being intensively studied as a possible anti-aging agent, and some amateur athletes have begun taking it "for longevity." However, several studies in elderly people have shown an unexpected result. In the MASTERS study (Walton et al., 2019), metformin attenuated muscle mass gains in response to resistance training.

In Konopka et al. (2019), metformin partially inhibited the improvements in mitochondrial function and insulin sensitivity normally produced by aerobic exercise. That is, the drug and physical activity do not always reinforce each other.

Whether this applies to berberine is unknown: there are actually no similar studies with a combination of berberine and training in humans. Theoretically, since both substances act in part through the energy stress of the cell, a similar interaction is possible, but this is only a hypothesis.

Practical conclusion for healthy exercisers: There is no evidence that any of these substances improve athletic performance or body composition over and above the effects of exercise and nutrition, and there is evidence for possible attenuation of adaptation for metformin.

Practical issues: quality, doses, interactions

If a person is considering berberine as a supplement, the following research context matters; these are not instructions for self-treatment. Pay attention to several points. In clinical studies, 0.5 g two to three times a day with meals was most often used, up to a total of 1.5 g per day. Taking with food reduces gastrointestinal discomfort, and dividing into several doses is associated with a short period of action and low bioavailability.

• Choose products with independent quality certification (third-party laboratory tests).
• Do not combine berberine with hypoglycemic drugs without consulting a doctor because of the risk of hypoglycemia.
• Berberine interacts with CYP liver enzymes and may alter the levels of other drugs, including cyclosporine.
• Berberine is contraindicated during pregnancy, breastfeeding and young children.

Metformin is taken only as prescribed by a doctor. The dose is selected gradually by the doctor to reduce gastrointestinal effects; in the instructions, the maximum daily dose is about 2–2.5 g, depending on the form and country. Before prescribing, kidney function is assessed, and during long-term treatment, the level of vitamin B12.

Both substances are not on the WADA Prohibited List, so from an anti-doping point of view they do not pose a problem. However, athletes should be aware of the risk of contamination of supplements with other substances.

Editorial conclusions

Metformin and berberine share common features: both lower glucose levels and act in part through similar cellular mechanisms. However, metformin is a standardized medication with a large evidence base for hard endpoints, and berberine is a supplement with compelling but mostly short-term data.

Berberine has lipid benefits but more drug interactions and lack of long-term safety data. Calling it "natural metformin" is a misleading oversimplification.

People with diabetes should not replace metformin with berberine on their own. None of these substances have proven benefits in healthy exercisers, and metformin may impair adaptation to exercise.

We also advise you to familiarize yourself with our materials on the mechanism of action and side effects of metformin and berberine, on insulin resistance and on glycated hemoglobin analysis.

References

1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–865.
2. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
3. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712–717.
4. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10(12):1344–1351.
5. Walton RG, Dungan CM, Long DE, et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: a randomized, double-blind, placebo-controlled, multicenter trial: the MASTERS trial. Aging Cell. 2019;18(6):e13039.
6. Konopka AR, Laurin JL, Schoenberg HM, et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019;18(1):e12880.
7. American Diabetes Association. Standards of Care in Diabetes. Diabetes Care. поточна редакція.